John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$230M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$207M |
| 3 |
EA
Electronic Arts
EA
|
+$205M |
| 4 |
Starbucks
SBUX
|
+$171M |
| 5 |
Baidu
BIDU
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$185M |
| 2 |
Elevance Health
ELV
|
+$180M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$169M |
| 4 |
Walt Disney
DIS
|
+$168M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$166M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.51% |
| 2 | Technology | 14.81% |
| 3 | Industrials | 12.21% |
| 4 | Healthcare | 10.11% |
| 5 | Financials | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRX
726
DELISTED
Akorn Inc
AKRX
| $5.94M | 0.02% |
1,752,624
+762,226
| +77% | +$4.53M |
|
727
Idexx Laboratories
IDXX
$44.1B
| $5.92M | 0.02% |
31,835
+11,434
| +56% | +$2.34M |
|
728
Designer Brands
DBI
$297M
| $5.92M | 0.02% |
239,733
-1,028,179
| -81% | -$27.6M |
|
|
VNTR
729
DELISTED
Venator Materials PLC
VNTR
| $5.92M | 0.02% |
1,412,962
+759,495
| +116% | +$4.91M |
|
730
Zscaler
ZS
$28.5B
| $5.9M | 0.02% |
+150,471
| New | +$5.68M |
|
|
CRC
731
DELISTED
California Resources Corporation
CRC
| $5.9M | 0.02% |
346,062
-313,485
| -48% | -$8.93M |
|
732
Flowers Foods
FLO
$1.54B
| $5.89M | 0.02% |
319,162
+156,237
| +96% | +$2.99M |
|
733
Enova International
ENVA
$6.17B
| $5.89M | 0.02% |
302,819
+61,111
| +25% | +$1.39M |
|
734
SS&C Technologies
SSNC
$19.6B
| $5.89M | 0.02% |
+130,643
| New | +$6.34M |
|
735
iShares US Aerospace & Defense ETF
ITA
$14B
| $5.86M | 0.02% |
67,800
-5,600
| -8% | -$540K |
|
|
CNR
736
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $5.83M | 0.02% |
804,882
+312,429
| +63% | +$3.75M |
|
|
IDTI
737
DELISTED
Integrated Device Technology I
IDTI
| $5.83M | 0.02% |
120,429
-126,271
| -51% | -$5.96M |
|
738
CareDx
CDNA
$2.46B
| $5.8M | 0.02% |
230,804
-242,741
| -51% | -$6.24M |
|
|
ETFC
739
DELISTED
E*Trade Financial Corporation
ETFC
| $5.8M | 0.02% |
132,209
+80,447
| +155% | +$3.94M |
|
740
Bank of America
BAC
$436B
| $5.78M | 0.02% |
234,402
-2,924,618
| -93% | -$79.3M |
|
|
PTR
741
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $5.78M | 0.02% |
93,843
+38,042
| +68% | +$2.72M |
|
742
PUT
Western Digital
WDC
$157B
| $5.78M | 0.02% |
206,653
+133,756
| +183% | +$4.74M |
|
|
WBS
743
DELISTED
Webster Financial
WBS
| $5.76M | 0.02% |
116,883
+96,640
| +477% | +$5.52M |
|
744
Sinclair Inc
SBGI
$1.05B
| $5.74M | 0.02% |
217,920
+18,654
| +9% | +$544K |
|
|
HI
745
DELISTED
Hillenbrand
HI
| $5.74M | 0.02% |
151,261
+127,729
| +543% | +$5.83M |
|
746
Karyopharm Therapeutics
KPTI
$42.2M
| $5.73M | 0.02% |
40,744
+14,147
| +53% | +$2.39M |
|
747
Kinross Gold
KGC
$39.1B
| $5.7M | 0.02% |
1,757,829
+285,379
| +19% | +$799K |
|
|
VMRK
748
Vivmark Residential
VMRK
$25.5B
| $5.69M | 0.02% |
86,144
-73,290
| -46% | -$4.92M |
|
749
Mueller Water Products
MWA
$3.93B
| $5.68M | 0.02% |
624,490
+422,216
| +209% | +$4.43M |
|
750
Unilever
UL
$141B
| $5.67M | 0.02% |
+96,489
| New | +$5.82M |
|
Similar funds
John Overdeck's Q4 2018 Portfolio in Review
As of Q4 2018, John Overdeck held 3,851 positions worth $25.5B, down 30% from $36.7B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
John Overdeck withdrew a net $5.25B in Q4 2018, closing 943 positions and reducing 1,216 holdings. Its most notable exit was Elevance Health, an estimated $180M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
Against the trend, John Overdeck opened a new position in Starbucks worth $176M.
- John Overdeck's largest Q4 2018 buy was Starbucks: 2,727,875 shares worth $176M.
- John Overdeck added most to SLB Ltd in Q4 2018, an estimated $230M increase.
- John Overdeck's biggest Q4 2018 reduction was Procter & Gamble, cutting an estimated $185M.
- John Overdeck fully exited Elevance Health in Q4 2018, selling an estimated $180M.
- John Overdeck's ten largest holdings make up 6.8% of its $25.5B portfolio in Q4 2018.
- John Overdeck opened 729 new positions and closed 943 in Q4 2018.
- John Overdeck's portfolio value fell 30% quarter-over-quarter to $25.5B.
Based on Two Sigma Investments's 13F filing for Q4 2018, filed 14 Feb 2019.